Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
IVVD compared with MNPR: revenue, margins and what each company keeps, and the suppliers and customers both name
IVVD
Invivyd, Inc.
Change
Mkt cap
Revenue
Revenue
MNPR
Monopar Therapeutics
Change
Mkt cap
Revenue
Revenue
vs
Compare
IVVD
Invivyd, Inc.
vs
MNPR
Monopar Therapeutics
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only IVVD
9
—
Undisclosed specialty distributor customer
unlisted
customer
—
Adimab
unlisted
supplier
—
WuXi Biologics
unlisted
supplier
—
WuXi Biologics (Hong Kong)
unlisted
supplier
5 more · IVVD chain
›
Shared
0
No shared counterparties.
Only MNPR
2
AZN
AstraZeneca
supplier
—
NorthStar
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
IVVD
Invivyd, Inc.
Change
0.58
· pre 0.57
· delayed
Mkt cap
$171.5M
Revenue
$14M
Q2 FY26
Revenue
$53M
FY25
MNPR
Monopar Therapeutics
Change
66.46
· pre 66.45
· delayed
Pre-market
Nov 2 '26
delayed
Mkt cap
$444.9M
Revenue
—
Revenue
—
vs
Compare
Pre-market
Nov 2 '26
delayed
IVVD
Invivyd, Inc.
vs
MNPR
Monopar Therapeutics
0.58
pre 0.57
delayed
Price
66.46
pre 66.45
delayed
$171.5M
Mkt cap
$444.9M
Q2 FY26
$14M
Revenue
—
FY25
$53M
Revenue
—
Change
Change
IVVD
0.58
vs
MNPR
66.46
Pre-market
Nov 2 '26
delayed